两阶段翻修前交叉韧带重建:用于骨隧道增强的骨移植材料选择的系统综述
本系统综述纳入7项研究共234例患者,比较两阶段翻修前交叉韧带重建中不同骨移植材料的结果。自体骨移植(髂嵴骨或胫骨骨)在4项研究中报告,同种异体骨基质或骨碎块在2项研究中报告,1项研究比较髂嵴骨与合成骨替代物。现有数据提示,与同种异体骨相比,两阶段翻修前交叉韧带重建中采用自体骨进行骨隧道移植可能与较低的翻修前交叉韧带重建移植物失败风险相关。
要点
- 7项研究共234例患者,两阶段翻修前交叉韧带重建的骨移植材料选择尚无共识。
- 髂嵴骨自体移植平均两次手术间隔6.1个月,同种异体和合成骨移植平均8.7个月。
- 翻修前交叉韧带移植物失败率:同种异体骨基质6.1%、同种异体骨碎块8.3%、胫骨自体骨0%、髂嵴骨0%和2%。
核心结论
- 两阶段前交叉韧带重建的适应证和阶段间康复方案需要明确建立。
- 现有数据表明,与同种异体骨相比,两阶段翻修前交叉韧带重建中采用自体骨进行骨隧道移植可能与较低的翻修前交叉韧带重建移植物失败风险相关。
研究设计与样本
- 系统综述,遵循PRISMA指南,检索PubMed、EMBASE和Cochrane Library,检索词为前交叉韧带和翻修。
- 纳入7项研究,共234例患者。
主要发现
- 2项研究的主要结局为移植物整合(平均随访8.8个月),其余5项研究报告临床结局,平均随访4.2±2.1年。
- 4项研究使用自体骨:髂嵴骨自体移植(n=3)和胫骨骨自体移植(n=1);2项研究使用同种异体骨基质和同种异体骨碎块;1项研究比较髂嵴骨与合成骨替代物。
- 4项研究报告第一阶段后骨移植整合的影像学评估,平均持续时间4.9个月。
- 4项研究报告两次手术间隔时间,髂嵴骨平均6.1个月,同种异体和合成骨移植平均8.7个月。
- 5项研究报告翻修前交叉韧带移植物失败率:同种异体骨基质6.1%(1项研究)、同种异体骨碎块8.3%(1项研究)、胫骨自体骨0%(1项研究)、髂嵴骨0%和2%(2项研究)。
局限性
- 两阶段前交叉韧带重建的适应证和阶段间康复方案在各研究间存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: No consensus is available regarding the optimal choice of bone graft material for bone tunnel augmentation in revision anterior cruciate ligament (ACL) surgery. PURPOSE: To compare the outcomes of different bone graft materials for staged revision ACL reconstruction. STUDY DESIGN: Systematic review. METHODS: A systematic review using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines was performed. PubMed, EMBASE, and the Cochrane Library were queried through use of the terms anterior cruciate ligament and revision to identify all studies reporting outcomes of bone tunnel grafting in 2-stage revision ACL reconstruction. Data extracted included indications for 2-stage surgery, surgical technique, graft material, time between surgeries, rehabilitation protocols, physical examination findings, patient-reported outcomes, and radiographic and histologic findings. RESULTS: The analysis included 7 studies with a total of 234 patients. The primary outcome in 2 studies was graft incorporation (mean follow-up, 8.8 months), whereas the other 5 studies reported clinical outcomes with follow-up mean ± SD of 4.2 ± 2.1 years. The indication for bone grafting and between-stage protocol varied among studies. Autograft was used in 4 studies: iliac crest bone autograft (ICBG, n = 3) and tibial bone autograft (TBA, n = 1). In 2 studies, the authors investigated the outcomes of allograft: allograft bone matrix (ABM) and allograft bone chips (AC). Finally, 1 study compared ICBG to a synthetic bone substitute. Radiographic evaluation of bone graft integration after the first stage was reported in 4 studies, with an average duration of 4.9 months. In 4 studies, the authors reported the time interval between first and second surgeries, with an average of 6.1 months for ICBG compared with 8.7 months for allogenic and synthetic grafts. Revision ACL graft failure rates were reported by 5 studies, including 1 study with ABM (6.1%), 1 study with AC (8.3%), 1 study with TBA (0%), and 2 studies with ICBG (0% and 2%). CONCLUSION: The indications for staged ACL reconstruction and the rehabilitation protocol between stages need to be clearly established. The available data indicate that autograft for bone tunnel grafting in 2-stage ACL revision may be associated with a lower risk of revision ACL reconstruction graft failure compared with allograft bone.
引用
- Salem HS, Axibal DP, Wolcott ML, et al. Two-Stage Revision Anterior Cruciate Ligament Reconstruction: A Systematic Review of Bone Graft Options for Tunnel Augmentation. Am J Sports Med. 2019. PMID: 31116949. doi:10.1177/0363546519841583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。